Furthermore, the adaptive deletion of PTEN in brain metastatic tumor cells leads to increased secretion of chemokine CCL2, which recruits microglia expressing CCL2 receptor (CCR2) to mutually promote the growth of brain metastatic tumor cells by enhancing proliferation and reducing apoptosis [58]. Here, CCR2 is linked to neoplasm.